openPR Logo
Press release

Pet OTC Medication Market is Expected to Reach US$ 13.2 Billion by 2032, with Demand Surging at a CAGR of 4.5% by 2032 | FMI

Pet OTC Medication Market

Pet OTC Medication Market

The Pet OTC Medication Market is poised to reach a valuation of US$ 8.5 Billion in 2022. Sales are projected to increase at a 4.5% CAGR, with the market size reaching US$ 13.2 Billion by 2032.

The global  pet OTC   (over-the-counter) medication is forecast to grow at a steady rate during the assessment period. Rising pet adoption across the globe is expected to push sales in the market through 2032. Increasing awareness regarding pet healthcare has also made a significant contribution to the growth in pet OTC medication market.

Emerging markets in low and middle-income countries are expected to offer opportunities for expansion. In addition to this, surging demand for herbal topical medication for fleas and other allergies in pets will boost sales in the market.

"Rising availability of pet insurance in countries such as the U.S. and France, along with increasing demand for natural ingredient-based pet care products is expected to fuel the growth in the market over the assessment period," says an FMI analyst.

Get your Sample Report to Boost Your Industry Knowledge for Valuable Insights!  https://www.futuremarketinsights.com/reports/sample/rep-gb-15353

Key Takeaways:

Demand for natural ingredients-based medications is expected to gain traction at a considerable pace.
Chewables and tablets will account for nearly 30% of the total market share over the forecast period.
Total sales of OTC medicines for dogs will hold approximately 40% of the global pet OTC medication market share.
The U.S. will continue dominating the North America pet OTC medication market over the assessment period, with sales growing at a 2% CAGR.
Demand in the India market is forecast to surge at a 5.5% CAGR through 2032.
France will account for a lion's share in the Europe pet OTC medication market over the forecast period.

Competition Landscape

The key players in the pet OTC medication market are Ceva Santé Animale Co., Elanco Animal Health Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., Merck & Co., Inc., Virbac SA Co., Bayer AG, IDEXX Laboratories Co., Covetrus Inc., Dechra Pharmaceuticals PLC, Vetoquinol SA, Phibro Animal Health Co., Kyoritsuseiyaku Co., Krka, d. d., Novo Mesto, Sequent Scientific Ltd., Heska Co., Eco Animal Health Group, and Neogen Co.

 Request the full report methodology now!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-15353      

Pet OTC Medication Market by Category

Pet Type:

Dogs
Cats
Birds
Fish and Reptiles
Small Pets
Others

Application:

Fleas & Ticks
Allergies
Pain Relief & Arthritis
De-wormers
Others

Form:

Chewables & Tablets
Capsules & Ointment
Sprays
Others

Sales Channel:

Pet Specialty Stores
Veterinary Clinics
Drug & Pharmacy Stores
Online Retail
Others

Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
MEA

Read Related Reports:

Pet Water Dispenser Market - https://www.futuremarketinsights.com/reports/pet-water-dispenser-market

Pet Transporting Service Market - https://www.futuremarketinsights.com/reports/pet-transporting-service-market

Pet Treats and Chews Market - https://www.futuremarketinsights.com/reports/pet-treats-and-chews-market

Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
LinkedIn| Twitter| Blogs | YouTube
For Sales Enquiries: sales@futuremarketinsights.com

About Future Market Insights, Inc.
Future Market Insights, Inc. (ESOMAR certified, Stevie Award - recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pet OTC Medication Market is Expected to Reach US$ 13.2 Billion by 2032, with Demand Surging at a CAGR of 4.5% by 2032 | FMI here

News-ID: 3185530 • Views:

More Releases from Future Market Insights Inc

Continuous Cardiac Monitoring Devices Market Size and Share Forecast Outlook 2025 to 2035
Continuous Cardiac Monitoring Devices Market Size and Share Forecast Outlook 202 …
The global Continuous Cardiac Monitoring Devices Market is poised for steady expansion, estimated at USD 8.8 billion in 2025 and projected to reach USD 19.2 billion by 2035, registering a compound annual growth rate (CAGR) of 8.1%. Rising cardiovascular disease prevalence, aging populations, and technological advancements in wearable and remote cardiac monitoring are driving sustained industry momentum. Dive Deeper into the Data-View the Full Report Here: https://www.futuremarketinsights.com/reports/continuous-cardiac-monitoring-devices-market Market Overview Cardiovascular diseases (CVDs)
Patisserie Packaging Market to Hit USD 11.1 Billion by 2035, Driven by E-commerce and Premiumization
Patisserie Packaging Market to Hit USD 11.1 Billion by 2035, Driven by E-commerc …
A new market analysis reveals significant growth potential for the global patisserie packaging sector, projecting its market value to surge from USD 7.1 billion in 2025 to a commanding USD 11.1 billion by 2035. This robust expansion is anticipated to register a Compound Annual Growth Rate (CAGR) of 4.6% over the forecast period, as premium bakery products, e-commerce, and a global push for sustainable solutions redefine the industry. The surge in
Smart Plant-Based Food Packaging Market Projected to Nearly Double by 2035, Driven by Green Technology
Smart Plant-Based Food Packaging Market Projected to Nearly Double by 2035, Driv …
A new market forecast highlights the explosive growth potential of the Smart Plant Based Food Packaging market, projecting a near-doubling in valuation over the next decade. According to the report, the global market, estimated at USD 291.5 billion in 2025, is anticipated to surge to USD 576.1 billion by 2035, exhibiting a robust Compound Annual Growth Rate (CAGR) of 7.1%. The surge reflects a global pivot toward sustainable logistics and packaging,
Resealable Packaging Labels Market Projected to Soar to USD 27.4 Billion by 2035, Driven by Global Demand for Convenience
Resealable Packaging Labels Market Projected to Soar to USD 27.4 Billion by 2035 …
A new comprehensive market report reveals that the global Resealable Packaging Labels Market is set for robust growth, with its value estimated to surge from USD 16.0 billion in 2025 to USD 27.4 billion by 2035. The market is projected to expand at a steady Compound Annual Growth Rate (CAGR) of 5.5% over the forecast period, reflecting a paradigm shift in consumer priorities toward product convenience, guaranteed freshness, and enhanced

All 5 Releases


More Releases for OTC

Lawsuit filed for Investors who lost money with shares of adidas AG (OTC: ADDYY, …
An investor, who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), filed a lawsuit over alleged violations of Federal Securities Laws by adidas AG in connection with certain allegedly false and misleading statements. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and for certain investors are short and strict deadlines running. Deadline: June 27, 2023. adidas AG (OTC: ADDYY, OTC: ADDDF) investors should contact
Investigation for Investors in adidas AG (OTC: ADDYY, OTC: ADDDF) announced over …
An investigation on behalf of investors in shares of adidas AG (OTC: ADDYY, OTC: ADDDF) was announced over potential breaches of fiduciary duties by certain officers and directors at adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain adidas AG officers and
AMERICAN HEMP VENTURES INC (OTC: AMHV) TO BECOME YOUNEEQAI TECHNICAL SERVICES In …
FOR IMMEDIATE RELEASE Denver Colorado, March 31, 2023, American Hemp Ventures, Inc. (OTC: AMHV) announced today that its name has changed effective immediately to YouneeqAI Technical Services inc. (OTC: YQAI) reflecting the Company's new focus into cookie-less AI technology services. The current management team has over 50 years of experience in technology services and innovation. Murray Galbraith, YQAI's CEO, is the Founder of YouneeqAI's software solution and has operated several private technology
Investigation announced for Investors who lost money with shares of adidas AG (O …
An investigation was announced for investors of adidas AG (OTC: ADDYY, OTC: ADDDF) shares over potential securities laws violations by adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of adidas AG (OTC: ADDYY,
Fuel Cell Market Technological Trends and Business Opportunities 2021 To 2026; P …
MarketInsightsReports has published a report titled global Fuel Cell Market research report 2021 that is a detailed observation of several aspects, including the rate of growth, technological advances, and different methodologies implemented by the primary current market players. The report is based on a collective analysis of data, which is obtained through primary and secondary research. It provides a systematic approach to the current and prospective scenario of this market. The
Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF). Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to